Testosterone therapy's big week: One urologist's perspective
March 16th 2017Abraham Morgentaler, MD, shares why the recent publication of five studies on testosterone therapy in JAMA and JAMA Internal Medicine "was arguably the most important week ever for the science of testosterone therapy and its impact on men's health."
Immunotherapy found efficacious as second-line therapy
March 14th 2017Results of an international randomized phase III study show that pembrolizumab (Keytruda) as second-line therapy for advanced urothelial carcinoma provided superior overall survival and a better safety profile compared with commonly used chemotherapy options.
Take charge of your online reputation
March 9th 2017Love them or hate them, online reviews are reality and powerful decision-making tools for patients searching for urologists and other physicians online. Managing or mismanaging a doctor’s online reputation can make-even threaten to break-a practice.
MRI, ultrasound detect post-burst wave lithotripsy injury
March 1st 2017Researchers who are investigating burst-wave lithotripsy, a potential alternative treatment for kidney stones, report that magnetic resonance imaging and ultrasound scans hold promise as tools to help scientists analyze related kidney injuries.
Perioperative surgical home model reduces LOS
March 1st 2017The perioperative surgical home is a promising model for delivering high-quality, cost-effective care for patients undergoing inpatient urologic procedures, according to the experience of urologists from Loma Linda University, Loma Linda, CA.
Testis Ca care deviates from guidelines in 30% of patients
March 1st 2017Nearly one-third of men with testicular cancer undergo diagnostic or therapeutic interventions that are at odds with guidelines from the National Comprehensive Cancer Network (NCCN), according a study published in the Journal of Urology (2017; 197:684-9).
What will replace the Affordable Care Act?
February 23rd 2017President Trump’s campaign promise to “repeal and replace” the Affordable Care Act has proved to be easier said than done as Republicans who control Congress have been unable to devise a workable and acceptable replacement for the controversial health care law.
Cyclosporine shows efficacy in refractory IC patients
February 23rd 2017Oral cyclosporine can offer a safe and effective treatment option for refractory interstitial, even in patients who have been on chronic narcotic medications and particularly in those with Hunner’s lesions, according to the findings of a study presented by Cleveland Clinic urologists at the 2016 AUA annual meeting in San Diego.